{
    "organizations": [],
    "uuid": "92f995ffc2283d2a5115599ad0ac77c280ba857e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-us-stem-cell-announces-intention-t/brief-us-stem-cell-announces-intention-to-vigorously-defend-a-lawsuit-filed-on-may-9-by-u-s-doj-at-request-of-u-s-fda-idUSFWN1SG1NF",
    "ord_in_thread": 0,
    "title": "BRIEF-Us Stem Cell Announces Intention To \"Vigorously Defend\" A Lawsuit Filed On May 9 By U.S. DOJ At Request Of U.S. FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - US Stem Cell Inc:\n* US STEM CELL - ANNOUNCED INTENTION TO “VIGOROUSLY DEFEND” A LAWSUIT FILED ON MAY 9 BY U.S. DOJ AT REQUEST OF U.S. FDA\n* US STEM CELL - U.S. DOJ LAWSUIT AT FDA’S REQUEST SEEKS TO STOP CO FROM PERFORMING SURGICAL PROCEDURE USING STEM CELLS FROM AUTOLOGOUS ADIPOSE TISSUE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T01:51:00.000+03:00",
    "crawled": "2018-05-10T02:05:40.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "u",
        "stem",
        "cell",
        "inc",
        "u",
        "stem",
        "cell",
        "announced",
        "intention",
        "vigorously",
        "defend",
        "lawsuit",
        "filed",
        "may",
        "doj",
        "request",
        "fda",
        "u",
        "stem",
        "cell",
        "doj",
        "lawsuit",
        "fda",
        "request",
        "seek",
        "stop",
        "co",
        "performing",
        "surgical",
        "procedure",
        "using",
        "stem",
        "cell",
        "autologous",
        "adipose",
        "tissue",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}